D2R | DNA to RNA - McGill University

Main navigation

D2R News

Stay informed about D2R updates by subscribing to our mailing list!

DNA to RNA (D2R)

An inclusive Canadian approach to genomic-based RNA therapeutics

The time is now for discovery and development of genome-guided, RNA-based precision medicines for Canada and for the world. With a landmark $165 million investment from the Canada First Research Excellence Fund, McGill’s world-leading research initiative DNA to RNA (D2R) will develop revolutionary genomic-based RNA medicines for all people of Canada.

Discover the initiative

women in a lab coat conducting tests in a lab

Open funding opportunities

Major Partnerships

Facilitating engagement of external partners.

Commercialization Priming

Supporting early-stage efforts that test or validate the commercial potential.

View D2R funding opportunities

Meet D2R Researchers

Curious about the research supported by D2R? Watch the videos below of D2R-funded researchers sharing insights into their projects and what drives their passion for research.

D2R represents a unique constellation of outstanding and internationally recognized experts working together across Canada to drive D2R’s outcome-driven initiative

The D2R Network